Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

RPTX Repare Therapeutics Inc

3,91

-0,11 (-2,74%)

07 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Small Cap Massively Bid Following Key Q1 Earnings Beat

A biotech company is turning heads so far during Wednesday’s premarket hours following the company reporting higher than expected revenue and EPS. According to a handful of...

To read the full story on AllPennyStocks.com, click here.

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Repare Therapeutics Charts.

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Repare Therapeutics Charts.

News Repare Therapeutics Inc

Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer
Dienstag 4 Juni 2024 (2 Tage vor) • Business Wire

Repare Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Montag 3 Juni 2024 (3 Tage vor) • Business Wire

Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024
Mittwoch 29 Mai 2024 (1 Woche vor) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Freitag 24 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Small Cap Massively Bid Following Key Q1 Earnings Beat
Mittwoch 8 Mai 2024 (4 Wochen vor) • AllPennyStocks.com

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
Dienstag 7 Mai 2024 (1 Monat vor) • Business Wire

DEBIOPHARM ET REPARE THERAPEUTICS ANNONCENT LE TRAITEMENT D’UN PREMIER PATIENT DANS LE CADRE DE L’ÉTUDE DE PHASE 1/1B MYTHIC ÉVALUANT LA COMBINATION D’INHIBITEURS WEE1 ET PKMYT1 GÉNÉRANT UNE LÉTHALITÉ SYNTHÉTIQUE
Dienstag 30 April 2024 (1 Monat vor) • Business Wire

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
Freitag 26 April 2024 (1 Monat vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Repare Therapeutics Inc News-Artikel

Deutsche Telekom

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen